Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
Clinical Phase I study with an Insulin-like Growth Factor-1 receptor inhibitor: experiences in patients with squamous non-small cell lung carcinoma. [electronic resource] by
- Ekman, Simon
- Frödin, Jan-Erik
- Harmenberg, Johan
- Bergman, Antonina
- Hedlund, Asa
- Dahg, Pia
- Alvfors, Carina
- Ståhl, Birgitta
- Bergström, Stefan
- Bergqvist, Michael
Producer: 20110701
In:
Acta oncologica (Stockholm, Sweden) vol. 50
Availability: No items available.
|
|
26.
|
|
|
27.
|
Dose-effect relationship of bolus 5-fluorouracil in the treatment of advanced colorectal cancer. [electronic resource] by
- Jakobsen, Anders
- Berglund, Ake
- Glimelius, Bengt
- Frödin, Jan-Erik
- Hansen, Flemming
- Kjaer, Mogens
- Madsen, Ebbe Lindegaard
- Sandberg, Erik
- Poulsen, Jan Peter
- Carlsson, Göran
- Gustavsson, Bengt
Producer: 20030206
In:
Acta oncologica (Stockholm, Sweden) vol. 41
Availability: No items available.
|
|
28.
|
|
|
29.
|
Correction: Durable Carcinoembryonic Antigen (CEA)-Specific Humoral and Cellular Immune Responses in Colorectal Carcinoma Patients Vaccinated with Recombinant CEA and Granulocyte/Macrophage Colony-Stimulating Factor. [electronic resource] by
- Ullenhag, Gustav J
- Frödin, Jan-Erik
- Jeddi-Tehrani, Mahmood
- Lidströmer, Niklas
- Strigård, Karin
- Eriksson, Emma
- Samanci, Ali
- Choudhury, Aniruddha
- Nilsson, Bo
- Rossmann, Eva D
- Mosolits, Szilvia
- Mellstedt, Håkan
Publication details: Clinical cancer research : an official journal of the American Association for Cancer Research May 2019
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 25
Availability: No items available.
|
|
30.
|
Durable carcinoembryonic antigen (CEA)-specific humoral and cellular immune responses in colorectal carcinoma patients vaccinated with recombinant CEA and granulocyte/macrophage colony-stimulating factor. [electronic resource] by
- Ullenhag, Gustav J
- Frödin, Jan-Erik
- Jeddi-Tehrani, Mahmood
- Lidströmer, Niklas
- Strigård, Karin
- Eriksson, Emma
- Samanci, Ali
- Choudhury, Aniruddha
- Nilsson, Bo
- Rossmann, Eva D
- Mosolits, Szilvia
- Mellstedt, Håkan
Producer: 20041210
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 10
Availability: No items available.
|
|
31.
|
A retrospective study of extracolonic, non-endometrial cancer in Swedish Lynch syndrome families. [electronic resource] by
- Karimi, Masoud
- von Salomé, Jenny
- Aravidis, Christos
- Silander, Gustav
- Askmalm, Marie Stenmark
- Henriksson, Isabelle
- Gebre-Medhin, Samuel
- Frödin, Jan-Erik
- Björck, Erik
- Lagerstedt-Robinson, Kristina
- Lindblom, Annika
- Tham, Emma
Publication details: Hereditary cancer in clinical practice 2018
In:
Hereditary cancer in clinical practice vol. 16
Availability: No items available.
|
|
32.
|
A novel oral insulin-like growth factor-1 receptor pathway modulator and its implications for patients with non-small cell lung carcinoma: A phase I clinical trial. [electronic resource] by
- Ekman, Simon
- Harmenberg, Johan
- Frödin, Jan-Erik
- Bergström, Stefan
- Wassberg, Cecilia
- Eksborg, Staffan
- Larsson, Olle
- Axelson, Magnus
- Jerling, Markus
- Abrahmsen, Lars
- Hedlund, Åsa
- Alvfors, Carina
- Ståhl, Birgitta
- Bergqvist, Michael
Producer: 20170110
In:
Acta oncologica (Stockholm, Sweden) vol. 55
Availability: No items available.
|
|
33.
|
The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of radiotherapy for cancer including a prospective survey of radiotherapy practice in Sweden 2001--summary and conclusions. [electronic resource] by
- Ringborg, Ulrik
- Bergqvist, David
- Brorsson, Bengt
- Cavallin-Ståhl, Eva
- Ceberg, Jeanette
- Einhorn, Nina
- Frödin, Jan-Erik
- Järhult, Johannes
- Lamnevik, Gunilla
- Lindholm, Christer
- Littbrand, Bo
- Norlund, Anders
- Nylén, Urban
- Rosén, Måns
- Svensson, Hans
- Möller, Torgil R
Producer: 20031126
In:
Acta oncologica (Stockholm, Sweden) vol. 42
Availability: No items available.
|
|
34.
|
Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial. [electronic resource] by
- Sclafani, Francesco
- Kim, Tae Y
- Cunningham, David
- Kim, Tae W
- Tabernero, Josep
- Schmoll, Hans J
- Roh, Jae K
- Kim, Sun Y
- Park, Young S
- Guren, Tormod K
- Hawkes, Eliza
- Clarke, Stephen J
- Ferry, David
- Frodin, Jan-Erik
- Ayers, Mark
- Nebozhyn, Michael
- Peckitt, Clare
- Loboda, Andrey
- Watkins, David J
Producer: 20170501
In:
International journal of cancer vol. 140
Availability: No items available.
|
|
35.
|
A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory, KRAS Wild-Type, Metastatic Colorectal Cancer. [electronic resource] by
- Sclafani, Francesco
- Kim, Tae Y
- Cunningham, David
- Kim, Tae W
- Tabernero, Josep
- Schmoll, Hans J
- Roh, Jae K
- Kim, Sun Y
- Park, Young S
- Guren, Tormod K
- Hawkes, Eliza
- Clarke, Steven J
- Ferry, David
- Frödin, Jan-Erik
- Ayers, Mark
- Nebozhyn, Michael
- Peckitt, Clare
- Loboda, Andrey
- Mauro, David J
- Watkins, David J
Producer: 20160125
In:
Journal of the National Cancer Institute vol. 107
Availability: No items available.
|